05/14/2026
Alpha-Lipoic Acid for Diabetic Peripheral Neuropathy
Alpha-lipoic acid shows little to no benefit over placebo for improving symptoms or impairment
05/14/2026
Alpha-lipoic acid shows little to no benefit over placebo for improving symptoms or impairment
04/30/2026
Testosterone replacement therapy shows no clear benefit over placebo
04/23/2026
Sustained-release naltrexone reduces illicit opioid use compared to standard care but shows slightly worse outcomes than opioid agonists
04/09/2026
Gonadotropins increased live birth and clinical pregnancy rates
Read More about Gonadotropins for Infertility in Polycystic Ovary Syndrome04/07/2026
Surgery resulted in higher clinical improvement at long-term follow-up compared with splinting alone
Read More about Surgical vs. Nonsurgical Treatments for Carpal Tunnel Syndrome03/31/2026
Higher MAP targets are likely associated with increased 28-day all-cause mortality, less RRT-free days, and increased risk of arrhythmia
Read More about Higher Versus Lower Mean Arterial Blood Pressure Targets in Vasodilatory Shock02/17/2026
Extracorporeal cardiopulmonary resuscitation did not improve favorable neurological status at the shortest follow-up and at 6 months or reduce in-hospital mortality when compared to conventional ACLS
Read More about Extracorporeal Cardiopulmonary Resuscitation for Refractory Out-of-Hospital Cardiac Arrest02/12/2026
Intravenous thrombolysis lowered functional independence and increased deaths at 90 days
Read More about Intravenous Thrombolysis for Minor Acute Ischemic Stroke01/29/2026
Continuous positive airway pressure (CPAP) reduced risk of invasive mechanical ventilation (IMV) compared to standard oxygen therapy (SOT), while both CPAP and high-flow nasal cannula (HFNC) reduced treatment failure compared to SOT
Read More about Noninvasive Respiratory Support for Pediatric Acute Hypoxemic Respiratory Failure